Arcoma

Arcoma Net Change in Cash

The Net Change in Cash of Arcoma (ARCOMA.ST) as of Nov 1, 2026 is 21.94 M SEK. In the previous year, Net Change in Cash was 8.38 M SEK — a change of 161.98% (higher).

Net Change in Cash

21.94 MSEK

YoY

161.98%

Last updated:

Net Change in Cash of Arcoma is 2025 21.94 M SEK. Net Change in Cash of Arcoma was 2024 8.38 M SEK. It decreases by 161.98% higher compared to the previous year.

The Arcoma Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2018
3.36 M SEK
Jan 1, 2019
-5.61 M SEK
Jan 1, 2020
6.38 M SEK
Jan 1, 2021
-3.75 M SEK
Jan 1, 2022
4.83 M SEK
Jan 1, 2023
-4.66 M SEK
Jan 1, 2024
8.38 M SEK
Jan 1, 2025
21.94 M SEK
The Arcoma Net Change in Cash history
YEARNet Change in CashYoY
21.94 MSEK+161.98%
8.38 MSEK-279.76%
-4.66 MSEK-196.50%
4.83 MSEK-228.71%
-3.75 MSEK-158.80%
6.38 MSEK-213.77%
-5.61 MSEK-266.83%
3.36 MSEK-580.14%
-700,000.00SEK-65.97%
-2.06 MSEK-130.15%
6.82 MSEK-2,785.83%
-254,000.00SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Net Change in Cash of Arcoma is 21.94 M SEK in 2025.

Net Change in Cash of Arcoma changed from 8.38 M SEK to 21.94 M SEK, representing a 161.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Arcoma since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Arcoma

All Key Metrics — Arcoma